ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Lineagotica’s Guide to Multiple Myeloma. Use the menu to see other pages. Think of that menu as a roadmap to this full guide.
Myeloma is a blood cancer of cells found in the bone marrow, specifically the so-called “plasma cells.” The bone marrow is the spongy tissue inside your bones that normally creates the components of your blood. Plasma cells are normally a key part of the body's immune system. In particular, they produce antibodies that help the body fight infection. Myeloma begins when healthy plasma cells change and grow out of control. This may result in multiple bone lesions that increase the risks of fracture. This is why the term "multiple myeloma" is sometimes used.
Abnormal plasma cells can crowd out or suppress the growth of other cells in the bone marrow that produce red blood cells, white blood cells, and platelets. They also reduce the creation of normal plasma cells, which lowers a person’s immunity. This suppression may result in:
Anemia, from a shortage of red blood cells
Excessive bleeding from cuts, from a shortage of platelets
Decreased ability to fight infection, from a shortage of white blood cells and the body’s inability to respond to infection because of the presence of abnormal antibodies
It is important to note that, like regular plasma cells, myeloma cells can produce antibodies. But myeloma cells are unable to produce healthy, functioning antibodies. Instead, they make what is called “monoclonal protein,” or “M protein.” M protein can build up in the blood and urine, potentially damaging the kidneys and other organs, as well as reducing immunity. A healthy person who is found to have a small amount of this M protein is said to have monoclonal gammopathy of undetermined significance (MGUS).
Myeloma causes structural bone damage, which can result in weakened bones and leads to painful fractures or bone breaks over time. Myeloma is usually called multiple myeloma because most people (90% or more) have multiple bone lesions when diagnosed or lesions develop over the course of the illness.
Solitary plasmacytoma is a mass of myeloma cells that involves only 1 site in the bone or, less commonly, other organs, such as in the upper respiratory tract, including the nose and throat or gastrointestinal systems.
Extramedullary plasmacytoma describes myeloma that started outside the bone marrow in locations such as the lymph glands, sinuses, throat, liver, digestive tract, or under the skin.
Normal Bone Marrow
Click to Enlarge
Multiple Myeloma Disease
Click to Enlarge
These images used with permission by the College of American Pathologists.
Looking for More of an Introduction?
If you would like more of an introduction, explore these related items. Please note that these links will take you to other sections on Lineagotica:
ASCO Answers Fact Sheet: Read a 1-page fact sheet that offers an introduction to multiple myeloma. This fact sheet is available as a PDF, so it is easy to print out.
Lineagotica Patient Education Video: View a short video led by an ASCO expert and patient advocate that provides basic information and areas of research related to multiple myeloma..
The next section in this guide is Statistics. It helps explain how many people are diagnosed with multiple myeloma and general survival rates. Use the menu to choose another section to read in this guide.